News | Atherectomy Devices | January 10, 2022

Cardiovascular Systems Inc Recalls Wirion Embolic Protection Device Due Filters Breaking During Retrieval

The CSI Wirion atherectomy embolic protection device is being recalled due to complaints of filter breakage during retrieval.

The CSI Wirion atherectomy embolic protection device is being recalled due to complaints of filter breakage during retrieval.


January 10, 2022 — Cardiovascular Systems Inc. (CSI) is recalling the Wirion atherectomy embolic protection device system due to complaints of filter breakage during retrieval. Under certain circumstances, such as when the filter basket is too full, the filter assembly may become difficult to withdraw. In this situation, withdrawal may cause the Wirion system filter component to tear or separate, which may result in series adverse events such as embolization or the need for additional medical procedures.

Cardiovascular Systems Inc. has received reports of nine device malfunctions, but no reports of death related to this device issue.

The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

The Wirion system is used to hold debris or blood clots removed from the lower limbs during atherectomy.

There are 697 devices being recalled in the U.S. This includes all products and lots from Jan. 3, 2021 to Aug. 16, 2021. Distribution of the devices occurred between March 22, 2021 to Nov. 15, 2021. 

The company initiated the recall Nov. 22, 2021, when CSI sent an urgent notification recall letter to customers instructing them remove the device from distribution and return the device to Cardiovascular Systems Inc.

Customers in the U.S. with questions about this recall should contact Cardiovascular Systems Inc. by phone at (65) 259-2800.

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.

For more information: www.csi360.com

Find more atherectomy systems news

FDA Issues Final Guidance on Peripheral Vascular Atherectomy Devices
 


Related Content

News | Atherectomy Devices

Medtronic recently announced results from two studies evaluating the utility of atherectomy for peripheral endovascular ...

Home November 08, 2024
Home
News | Atherectomy Devices

February 15, 2023 — Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to ...

Home February 15, 2023
Home
News | Atherectomy Devices

July 28, 2022 — Northeast Scientific Inc., pioneers in reprocessing single use peripheral vascular catheters, announced ...

Home July 28, 2022
Home
News | Atherectomy Devices

March 9, 2022 — Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design ...

Home March 09, 2022
Home
News | Atherectomy Devices

January, 24, 2022 — Medtronic Inc. is recalling its HawkOne Directional Atherectomy System product due to the risk of ...

Home January 24, 2022
Home
News | Atherectomy Devices

July 20, 2020 – BD (Becton, Dickinson and Company) recently completed the acquisition of Straub Medical AG, a privately ...

Home July 20, 2020
Home
News | Atherectomy Devices

February 13, 2020 — The U.S. Food and Drug Administration (FDA) has issued its final guidance on "Peripheral Vascular ...

Home February 13, 2020
Home
News | Atherectomy Devices

November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

Home November 11, 2019
Home
News | Atherectomy Devices

November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...

Home November 07, 2019
Home
Technology | Atherectomy Devices

September 13, 2019 — Rex Medical L.P. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 13, 2019
Home
Subscribe Now